Clinical analysis of excimer laser atherectomy in the treatment of diabetic foot with infrapopliteal arteriopathy
10.3760/cma.j.cn431274-20221021-01048
- VernacularTitle:准分子激光销蚀术治疗糖尿病足膝下动脉病变的临床疗效分析
- Author:
Jiareke TANG
1
;
Chuanyang ZHANG
;
Jianping YANG
;
Hongbo CI
;
Xiaohu GE
;
Sheng GUAN
Author Information
1. 新疆维吾尔自治区人民医院血管外科，乌鲁木齐 830001
- Keywords:
Diabetic foot;
Angioplasty, balloon;
Lasers, excimer;
Infrapopliteal artery lesion
- From:
Journal of Chinese Physician
2022;24(12):1776-1779
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the clinical efficacy of excimer laser atherectomy (ELA) in the treatment of diabetic foot with infrapopliteal arteriopathy.Methods:The clinical data of 36 patients (40 limbs) with diabetic foot complicated with inferior knee artery disease treated by ELA in Xinjiang Uygur Autonomous Region People′s Hospital from December 2019 to May 2021 were analyzed retrospectively. The success rate of ELA in the treatment of diabetic inferior genicular artery disease, ankle-brachial index (ABI), limb salvage rate and Visual Analogue Scale (VAS) score at 3 days and 3 and 6 months after operation was observed.Results:All the 36 patients were operated successfully, including 2 cases of flow-limiting dissection, 2 cases of arterial embolism and 1 case of hematoma at the puncture point. The ABI of patients 3, 6 months after operation was significantly higher than that before operation (all P<0.05), and the VAS score 3, 6 months after operation was significantly lower than that before operation (all P<0.05). The rate of limb (toe) salvage were 92.5%(37/40), 82.5%(33/40) at 3 d, 3 months and 77.5%(31/40) at 6 months after operation. Conclusions:ELA is safe and effective in the treatment of diabetic foot infrapopliteal arteriopathy, and the recent efficacy is fair.
